There are more than 200 different compounds in development and I would say that probably more than 100 compounds are now [being tested] in humans. The research is moving quickly, and at the recent annual American Diabetes Association scientific conference, investigators released a flurry of new reports on the next generation of GLP-1 medications
Results vary, but many patients see improvements within the first few months when combined with lifestyle changes and medical guidance
Importantly, unlike traditional antidiabetic therapies that can cause weight gain, GLP1 RAs often result in modest to substantial weight loss, depending on dose and individual response
The sublingual formulation enhances the medications effectiveness by allowing for swift absorption into the bloodstream, resulting in faster impacts on appetite regulation and reducing gastrointestinal side effects commonly associated with oral GLP-1 agonists
doi:10.1186/1472-6963-10-159 Sarwer DB, Gasoyan H, Bauerle Bass S, Spitzer JC, Soans R, Rubin DJ
B12 & MIC Injections Essential for metabolism and fat breakdown, promoting sustained energy and body composition improvements